SoftBank Group (SFTBY) has taken a stake of about 6% in DNA-sequencing company Pacific Biosciences of California (PACB), Giles Turner of Bloomberg reports, citing a person with knowledge of the investment.
Image Source: Unsplash
The stake is currently worth more than $350M and highlights the expanding portfolio of public equity investments by SoftBank's asset management unit SB Northstar, the source told Bloomberg.
Shares of Pacific Biosciences are up 15%, or $4.88, to $37.77 following the report.
Comments
Log in or sign up to join the conversation.